ERBB2 showed the highest expression-driven dependency in the on-label breast cancer cells (R = −0.68, FDR = 2.5E − 3) along with significant expression-driven dependency in ovarian cancer cell lines (R = −0.53, FDR = 0.038; Fig. 5c). This evidence concerns the gene ERBB2 and ovarian carcinoma.